Back
TriplePoint Venture Growth BDC Corp. Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Sell
34
TPVG
TriplePoint Venture Growth BDC Corp.
Last Price:
$6.32
Seasonality Move:
-4.34%
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.10
Seasonality Move:
6.08%
Sell
34
TriplePoint Venture Growth BDC Corp. (TPVG)
is a Sell
Is TriplePoint Venture Growth BDC Corp. a Buy, Sell or Hold?
-
The current TriplePoint Venture Growth BDC Corp. [TPVG] share price is $6.32. The Score for TPVG is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
TPVG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.12. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TPVG Stock Price Chart
What is TriplePoint Venture Growth BDC Corp.'s stock price today?
-
The TriplePoint Venture Growth BDC Corp. share price today is $6.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPVG is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
TPVG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.71 | Buy |
| Relative Strength Index (14 RSI): | 50.85 | Buy |
| Chaikin Money Flow: | 130491 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.23 - 6.63) | Sell |
| Bollinger Bands (100): | (5.69 - 6.57) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.95 | Buy |
| Relative Strength Index (14 RSI): | 56.1 | Buy |
| Chaikin Money Flow: | -75967 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.51 - 22.53) | Buy |
| Bollinger Bands (100): | (17.83 - 22.33) | Buy |
TPVG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.24 | Buy |
| 20-day SMA: | 6.45 | Sell |
| 50-day SMA: | 6.07 | Buy |
| 200-day SMA: | 6.45 | Sell |
| 8-day EMA: | 5.19 | Buy |
| 20-day EMA: | 3.15 | Buy |
| 50-day EMA: | 1.53 | Buy |
| 200-day EMA: | 0.42 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.56 | Buy |
| 20-day SMA: | 21.6 | Buy |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 30.48 | Sell |
| 8-day EMA: | 17.99 | Buy |
| 20-day EMA: | 10.86 | Buy |
| 50-day EMA: | 5.25 | Buy |
| 200-day EMA: | 1.45 | Buy |
TriplePoint Venture Growth BDC Corp. Earnings Growth & TPVG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.11 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
TriplePoint Venture Growth BDC Corp. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||